Copper Cysteamine Nanoparticles Microwave Activation Cancer Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cancer treatment methods are inadequate in effectively targeting and destroying cancer cells, particularly in photodynamic therapy, where copper cysteamine nanoparticles are not efficiently activated to produce reactive oxygen species for cell death.

Innovation Solution

The use of copper cysteamine nanoparticles activated by microwave radiation to generate reactive oxygen species, such as singlet oxygen, which induces cell death in cancer cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If copper cysteamine nanoparticles are used in photodynamic therapy, then cancer cells can be targeted and destroyed through reactive oxygen species production, but the nanoparticles are not efficiently activated to produce sufficient reactive oxygen species for effective cell death

Engineering Contradiction:
Improvecancer cell destruction effectivenessVSAvoidreactive oxygen species production efficiency
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent changes the activation parameter from conventional light sources to microwave radiation, which fundamentally alters the energy interaction mechanism with copper cysteamine nanoparticles. This parameter change enables efficient generation of reactive oxygen species that was not achieved with traditional photodynamic therapy light sources, directly resolving the contradiction between nanoparticle activation efficiency and cancer cell destruction effectiveness

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent substitutes the conventional optical activation mechanism with a microwave-based activation system. This replacement of the activation mechanism enables the copper cysteamine nanoparticles to produce sufficient reactive oxygen species for effective cancer cell destruction, overcoming the limitation of inefficient activation in traditional photodynamic therapy

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination of copper cysteamine nanoparticles and microwave radiation effectively produces singlet oxygen, leading to significant tumor reduction and cell death, demonstrating a promising approach for cancer treatment.

Implementation Method 1

The disclosed methods of treatment utilize microwave radiation as a means for activating the copper cysteamine photosensitizer

Methodology Applied
Scientific EffectMicrowave radiation activation: Microwave Radiation

Implementation Method 2

the irradiated Cu-Cy particles generate highly reactive oxygen species (ROS) by means of photoexcitation

Methodology Applied
Scientific EffectPhotoexcitation: Photodissociation

Implementation Method 3

the irradiated Cu-Cy particles generate highly reactive oxygen species (ROS) by means of photoexcitation, such as hydroxyl radicals (.OH), singlet oxygen (1O2), as well as peroxides (R—O—O.)

Methodology Applied
Scientific EffectPhotoexcitation: Photodissociation

Implementation Method 4

which irreversibly damage a target of interest, for example, cancer cells

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS10661095B2Photodynamic therapy for use in treating cancer
Publication Date: 2020.05.26 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US10661095B2 patent drawing
  • US10661095B2 patent drawing
  • US10661095B2 patent drawing

AI summary

Disclosed is the use of copper cysteamine nanoparticles for use in photodynamic cancer therapy. The disclosed methods of treatment utilize microwave radiation as a means for activating the copper cysteamine photosensitizer.